Message From the Director
Welcome to the Stanford Diabetes Research Center (SDRC) website! We invite you to explore the site to learn more about our members, programs and goals. Our mission is to support basic and clinical research to discover, apply and translate science about diabetes and it complications, to improve health and wellness. The SDRC is founded on a base of superb, collaborative investigators studying basic, clinical and translational problems in diabetes at Stanford University and Stanford Health Care, which have a tradition and reputation for scientific innovation and clinical care, located in the heart of Silicon Valley, an epicenter of transformative discovery and calculated risk-taking. The Stanford Diabetes Research Center provides resources to support Research Cores, and a Pilot and Feasibility Award Program to foster innovative diabetes research, and Enrichment Programs focused on diabetes research, education and care. As part of Stanford University School of Medicine, the SDRC is also dedicated to training the next generation of researchers focused on diabetes and its complications.
The foundation of the Stanford Diabetes Research Center is its strong, diverse base of investigators in 23 departments and three schools within Stanford University (Schools of Medicine, Engineering, and of Humanities and Sciences). The SDRC research base is comprised of a broad group of outstanding faculty pursuing basic and clinical research. The senior faculty of the SDRC includes 12 current or previous investigators of the Howard Hughes Medical Institute, 12 members of the National Academies of Science, Medicine or Engineering, and a Nobel Laureate. These and other distinguished senior scientists harmonize with a vibrant core of junior SDRC investigators to form a superb research base distinguished by innovative basic and clinical science. The scientific investigations by SDRC members include the signaling and physiology of metabolism and energy homeostasis, the pathogenesis and treatment of type 1, type 2 and type 3c diabetes, diabetes complications or associated diseases like pancreas cancer, and modern bioengineering or behavioral approaches to translating new knowledge to clinical care. These interdisciplinary efforts are fostered by a unique, dynamic culture of collaboration, curiosity and ambition at Stanford that promotes and accelerates innovative, groundbreaking discovery focused on diabetes.